Suboptimal uptitration of secondary prevention medication following acute MI is not a problem unique to NHS Greater Glasgow and Clyde. Evidence from the UK and international healthcare systems highlights the need for further work.20–27 The optimisation of ACEI (or ARB) and beta-blocker seen in this programme is superior to that described in previous studies and, therefore, some of the learning may be applicable to other areas.25–27